Literature DB >> 12780769

Epidemiological and clinical characteristics of migraine and tension type headache in 1146 females in Kayseri, Turkey.

E Köseoglu1, M Naçar, A Talaslioglu, F Cetinkaya.   

Abstract

In a female population of Turkey (1146 adult females), some epidemiological and clinical characteristics of migraine and tension type headache and their subtypes were investigated. The relation of the headache severity to clinical characteristics were inquired. Migraine prevalence was found to be statistically higher in the 35-44 years age group (P < 0.01) and those who were university graduates (P < 0.001), married (P < 0.01) and living in urban areas (P < 0.01). Tension type headache was found to be higher in the 45-64 years age group (P < 0.05). Chronic tension type headache patients were found to be older than episodic type (P < 0.01) and frequently were in the lowest education level (P < 0.05). Presence of impact on daily activities because of the severity of headache was found to be related to aggravation by physical activities (P = 0.001) in tension type headache, with no clinical characteristics in migraine headache and on consideration of all headache patients with throbbing nature (P < 0.05), aggravation on physical activities (P = 0.001), nausea (P < 0.01), vomiting (P < 0.05) and phonophobia (P < 0.05).

Entities:  

Mesh:

Year:  2003        PMID: 12780769     DOI: 10.1046/j.1468-2982.2003.00533.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

1.  Associations of socioeconomic status with migraine and non-migraine headache.

Authors:  Anke C Winter; Klaus Berger; Julie E Buring; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-12-15       Impact factor: 6.292

Review 2.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

3.  Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

Authors:  Vincent T Martin; Jeanne Ballard; Michael P Diamond; Lisa K Mannix; Frederick J Derosier; Shelly E Lener; Alok Krishen; Susan A McDonald
Journal:  J Womens Health (Larchmt)       Date:  2014-02-28       Impact factor: 2.681

Review 4.  Menstrual migraine: a review of prophylactic therapies.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2004-06

5.  The PACE study: past-year prevalence of tension-type headache and its subtypes in Parma's adult general population.

Authors:  T Ferrante; G C Manzoni; M Russo; A Taga; C Camarda; L Veronesi; C Pasquarella; G Sansebastiano; P Torelli
Journal:  Neurol Sci       Date:  2014-08-11       Impact factor: 3.307

Review 6.  Epidemiology and cultural differences in tension-type headache.

Authors:  Kristen Sahler
Journal:  Curr Pain Headache Rep       Date:  2012-12

7.  Does sleep aggravate tension-type headache?: An investigation using computerized ecological momentary assessment and actigraphy.

Authors:  Hiroe Kikuchi; Kazuhiro Yoshiuchi; Yoshiharu Yamamoto; Gen Komaki; Akira Akabayashi
Journal:  Biopsychosoc Med       Date:  2011-08-12

8.  One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults.

Authors:  Mustafa Ertas; Betul Baykan; Elif Kocasoy Orhan; Mehmet Zarifoglu; Necdet Karli; Sabahattin Saip; Ayse Emel Onal; Aksel Siva
Journal:  J Headache Pain       Date:  2012-01-14       Impact factor: 7.277

Review 9.  Perspectives on next steps in classification of oro-facial pain - part 1: role of ontology.

Authors:  W Ceusters; A Michelotti; K G Raphael; J Durham; R Ohrbach
Journal:  J Oral Rehabil       Date:  2015-07-25       Impact factor: 3.837

10.  The validation of ID Migraine screener in neurology outpatient clinics in Turkey.

Authors:  Necdet Karli; Mustafa Ertas; Betül Baykan; Ozlem Uzunkaya; Sabahattin Saip; Mehmet Zarifoglu; Aksel Siva
Journal:  J Headache Pain       Date:  2007-09-24       Impact factor: 7.277

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.